G. Thinakaran et al., NOVEL REGULATION OF CHONDROITIN SULFATE GLYCOSAMINOGLYCAN MODIFICATION OF AMYLOID PRECURSOR PROTEIN AND ITS HOMOLOG, APLP2, The Journal of biological chemistry, 270(28), 1995, pp. 16522-16525
Alzheimer's disease is characterized by the presence of parenchymal an
d cerebrovascular deposits of beta-amyloid (A beta). A beta is derived
from larger amyloid precursor proteins (APP), a member of a family of
related polypeptides that includes amyloid precursor-like proteins, A
PLP1 and APLP2, APP and APLP2 isoforms are encoded by several alternat
ively spliced APP and APLP2 transcripts, respectively, We previously r
eported that the APLP2-751 isoform is modified by the addition of chon
droitin sulfate glycosminoglycan (CS GAG) at Ser-614, In this report,
we demonstrate that the APLP2-763 isoform, which contains an insertion
of 12 amino acids immediately N-terminal to Ser-614, is not modified
by CS GAG, Finally, we demonstrate that like APLP2-751, APP isoforms t
hat lack sequences encoded by exon 15 (L-APP) are also modified by CS
GAG, whereas APP forms containing exon 15 are not, We suggest that CS
GAG modification of a subset of APP and APLP2 isoforms represents a me
ans of generating functional diversity for these polypeptides.